EXHIBIT 10.18 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS([**]), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED...Collaboration Agreement • June 24th, 2004 • Viacell Inc • Services-commercial physical & biological research • New York
Contract Type FiledJune 24th, 2004 Company Industry Jurisdiction
ARTICLE 1 SCOPE OF COLLABORATION; COLLABORATION ACTIVITIESCollaboration Agreement • October 24th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 24th, 2001 Company Industry Jurisdiction
ARTICLE 1 SCOPE OF COLLABORATION; COLLABORATION ACTIVITIESCollaboration Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 10th, 2001 Company Industry Jurisdiction
ARTICLE 1 SCOPE OF COLLABORATION; COLLABORATION ACTIVITIESCollaboration Agreement • August 13th, 2001 • Northwest Biotherapeutics Inc • Textile mill products • New York
Contract Type FiledAugust 13th, 2001 Company Industry Jurisdiction
1 Exhibit 10.1 Certain Confidential Information contained in this document has been omitted and filed separately with the Securities and Exchange Commission. AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • August 14th, 2000 • Geltex Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 14th, 2000 Company Industry Jurisdiction
EXHIBIT 10.1Collaboration Agreement • February 24th, 2000 • Geltex Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 24th, 2000 Company Industry Jurisdiction
EXHIBIT 10.2Collaboration Agreement • February 24th, 2000 • Geltex Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 24th, 2000 Company Industry Jurisdiction
EXHIBIT 10.21 AGREEMENT BETWEEN CELL PATHWAYS AND THE DIVISION OF CANCER PREVENTION AND CONTROL, NATIONAL CANCER INSTITUTE FOR THE PRECLINICAL AND CLINICAL DEVELOPMENT OF PRE-CANCER AND CANCER AGENTSCollaboration Agreement • October 9th, 1997 • Cell Pathways Inc • District of Columbia
Contract Type FiledOctober 9th, 1997 Company Jurisdiction